Literature DB >> 16827788

Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells.

C Tian1, J Bagley, J Iacomini.   

Abstract

Genetic modification of hematopoietic stem cells (HSCs) resulting in a state of molecular chimerism can be used to induce donor-specific tolerance to allografts. However, the requirements for maintaining tolerance in molecular chimeras remain unknown. Here, we examined whether long-term expression of a retrovirally encoded alloantigen in hematopoietic cells is required to maintain donor-specific tolerance in molecular chimeras. To this end, mice were reconstituted with syngeneic bone marrow transduced with retroviruses carrying the gene encoding the allogeneic MHC class I molecule Kb. Following induction of molecular chimerism, mice were depleted of cells expressing Kb by administration of the anti-Kb monoclonal antibody Y-3. Mice that were effectively depleted of cells expressing the retrovirally encoded MHC class I antigen rejected Kb disparate skin allografts. In contrast, control molecular chimeras accepted Kb disparate skin allografts indefinitely. These data suggest maintenance of tolerance in molecular chimeras requires long-term expression of retrovirally transduced alloantigen on the progeny of retrovirally transduced HSCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827788     DOI: 10.1111/j.1600-6143.2006.01455.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

2.  Thymic gene transfer of myelin oligodendrocyte glycoprotein ameliorates the onset but not the progression of autoimmune demyelination.

Authors:  Christopher Siatskas; Natalie Seach; Guizhi Sun; Ashley Emerson-Webber; Aude Silvain; Ban-Hock Toh; Frank Alderuccio; B Thomas Bäckström; Richard L Boyd; Claude C Bernard
Journal:  Mol Ther       Date:  2012-02-21       Impact factor: 11.454

3.  Molecular chimerism in IgE-mediated allergy: B-and T-cell tolerance toward highly immunogenic exogenous antigens.

Authors:  Ulrike Baranyi; Rudolf Valenta; Thomas Wekerle
Journal:  Chimerism       Date:  2013 Jan-Mar

4.  Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen.

Authors:  U Baranyi; N Pilat; M Gattringer; B Linhart; C Klaus; E Schwaiger; J Iacomini; R Valenta; T Wekerle
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

5.  Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.

Authors:  Ulrike Baranyi; Andreas M Farkas; Karin Hock; Benedikt Mahr; Birgit Linhart; Martina Gattringer; Margit Focke-Tejkl; Arnd Petersen; Fritz Wrba; Thomas Rülicke; Rudolf Valenta; Thomas Wekerle
Journal:  EBioMedicine       Date:  2016-03-20       Impact factor: 8.143

6.  Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.

Authors:  Kunal H Bhatt; Rajeev Rudraraju; Jeremy F Brooks; Ji-Won Jung; Ryan Galea; James W Wells; Raymond J Steptoe
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

7.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.